MTOR and cancer: Moreover, samples with mtDNA truncating mutations showed upregulation of gene expression in cancer-related pathways, such as mammalian target of rapamycin signaling, tumor necrosis factor-α signaling, oxidative phosphorylation and protein secretion (false discovery rate (FDR) < 0.05; Fig. 3e).